Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Why OSR Health (OSRH) Stock Is Up Today

None

OSR Health (OSRH) is up 76.8% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear same-day catalyst is hard to pin down, so this looks at least partly speculative. The move may reflect renewed attention on OSR Health’s VXM01 oncology licensing deal, its related equity support features, and the kind of momentum-driven trading that often appears in small-cap biotech names facing a near-term Nasdaq compliance deadline.

Details:

  • In April 2026, OSR Health and its Vaximm unit signed a global exclusive VXM01 license agreement with BCM Europe that carries potential milestone payments of up to $815 million.
  • That same agreement gives OSR Health a right to require BCM Europe to buy up to $15 million of OSR Health common stock at $10.00 per share during a specified exercise window.
  • In May 2026, OSR Health agreed to acquire the full VXM01 intellectual property portfolio for $30 million so the parent company would directly hold the asset and any future milestone and royalty economics tied to it.
  • OSR Health also disclosed it received an additional 180-day Nasdaq extension, giving it until August 31, 2026 to regain compliance with the $1.00 minimum bid price rule, which can intensify volatility as that date approaches.
  • Sources:

    SEC, OSR Health, Nasdaq

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $OSRH Hedge Fund Activity

    We have seen 7 institutional investors add shares of $OSRH stock to their portfolio, and 9 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles